FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Torrance

Research Profile

Concepts & Ideas

Activities & Behaviors

Geographic Areas

Canada

Disorders

Co-author Network

Publications

TOP 3
Nicholas Bellamy; Mary J Bell; Charlie H Goldsmith; Shelley Lee; Michael Maschio; Jean-Pierre Raynauld; George W Torrance; Peter Tugwell
BLISS index using WOMAC index detects between-group differences at low-intensity symptom states in osteoarthritis.
Paul Grootendorst; Deborah Marshall; Dan Pericak; Nicholas Bellamy; David Feeny; George W Torrance
A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee.
Nicholas Bellamy; Mary J Bell; Dan Pericak; Charles H Goldsmith; George W Torrance; Jean-Pierre Raynauld; Valery Walker; Peter Tugwell; Richard Polisson
BLISS index for analyzing knee osteoarthritis trials data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Torrance (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Nicholas Bellamy; Mary J Bell; Charlie H Goldsmith; Shelley Lee; Michael Maschio; Jean-Pierre Raynauld; George W Torrance; Peter Tugwell
BLISS index using WOMAC index detects between-group differences at low-intensity symptom states in osteoarthritis.
Journal of clinical epidemiology 2010;63(5):566-74.
2007: Paul Grootendorst; Deborah Marshall; Dan Pericak; Nicholas Bellamy; David Feeny; George W Torrance
A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee.
The Journal of rheumatology 2007;34(3):534-42.
2007: Nicholas Bellamy; Mary J Bell; Dan Pericak; Charles H Goldsmith; George W Torrance; Jean-Pierre Raynauld; Valery Walker; Peter Tugwell; Richard Polisson
BLISS index for analyzing knee osteoarthritis trials data.
Journal of clinical epidemiology 2007;60(2):124-32.
2006: R Casey; Jean-Eric Tarride; Margaret-Anne Keresteci; George W Torrance
The Erectile Function Visual Analog Scale (EF-VAS): a disease-specific utility instrument for the assessment of erectile function.
The Canadian journal of urology 2006;13(2):3016-25; discussion 3026.
2006: Deborah A Marshall; Marcie Strauss; Dan Pericak; Melanie Buitendyk; Christine Codding; George W Torrance
Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
The American journal of managed care 2006;12(4):205-14.
2006: George W Torrance
Utility measurement in healthcare: the things I never got to.
PharmacoEconomics 2006;24(11):1069-78.
2006: George W Torrance; Margaret-Anne Keresteci; Richard Casey; Nancy C Ryan; Jean-Eric Tarride
Measuring quality of life: the development and initial validation of the patient-reported erectile function assessment instrument.
International journal of technology assessment in health care 2006;22(3):372-8.
2005: Jean-Pierre Raynauld; Charles H Goldsmith; George W Torrance
Letter to the Editor: Reply to the letter by Max I. Hamburger.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2005;13(11):1037-8; author reply 1039-40.
2005: Nicholas Bellamy; Mary J Bell; Charles H Goldsmith; Dan Pericak; Valery Walker; Jean-Pierre Raynauld; George W Torrance; Peter Tugwell; Richard Polisson
Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis.
Annals of the rheumatic diseases 2005;64(6):881-5.
2005: Jean-Pierre Raynauld; Charles H Goldsmith; Nicholas Bellamy; George W Torrance; Richard Polisson; D Belovich; Dan Pericak; Peter Tugwell
Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2005;13(2):111-9.
2005: Nicholas Bellamy; Mary J Bell; Charles H Goldsmith; Dan Pericak; Valery Walker; Jean-Pierre Raynauld; George W Torrance; Peter Tugwell; Richard Polisson
The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2005;13(2):104-10.
2004: George W Torrance; Peter Tugwell; S Amorosi; E Chartash; N Sengupta
Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate.
Rheumatology (Oxford, England) 2004;43(6):712-8.
2004: George W Torrance; Margaret-Anne Keresteci; R W Casey; Andrew Rosner; Nancy Ryan; M C Breton
Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(2):349-59.
2003: R Gary Sibbald; George W Torrance; Margaret Hux; Cheryl Attard; Natalie Milkovich
Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.
Ostomy/wound management 2003;49(11):76-84.
2003: George W Torrance; Michael F Drummond; Valery Walker
Switching therapy in health economics trials: confronting the confusion.
Medical decision making : an international journal of the Society for Medical Decision Making 2003;23(4):335-40.
2003: Margaret L McNeely; George W Torrance; David J Magee
A systematic review of physiotherapy for spondylolysis and spondylolisthesis.
Manual therapy 2003;8(2):80-91.
2002: Gillian R Currie; Cam Donaldson; Bernie J O'Bbrien; Greg L Stoddart; George W Torrance; Michael F Drummond
Willingness to pay for what? A note on alternative definitions of health care program benefits for contingent valuation studies.
Medical decision making : an international journal of the Society for Medical Decision Making 2002;22(6):493-7.
2002: Qinan Wang; William Furlong; David Feeny; George W Torrance; Ronald Barr
How robust is the Health Utilities Index Mark 2 utility function?
Medical decision making : an international journal of the Society for Medical Decision Making 2002;22(4):350-8.
2002: George W Torrance; Jean-Pierre Raynauld; Valery Walker; Charles H Goldsmith; Nicholas Bellamy; Philip Band; M Schultz; Peter Tugwell
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2002;10(7):518-27.
2002: Jean-Pierre Raynauld; George W Torrance; Philip Band; Charles H Goldsmith; Peter Tugwell; Valery Walker; M Schultz; Nicholas Bellamy
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2002;10(7):506-17.
2002: Cheryl Attard; Michele A Kohli; Suzanne Coleman; Cathy J Bradley; Margaret Hux; Gordana Atanackovic; George W Torrance
The burden of illness of severe nausea and vomiting of pregnancy in the United States.
American journal of obstetrics and gynecology 2002;186(5 Suppl Understanding):S220-7.
2002: George W Torrance
Looking back and looking forward: viewed through the eyes of George Torrance.
Medical decision making : an international journal of the Society for Medical Decision Making 2002;22(2):178-81.
2002: David Feeny; William Furlong; George W Torrance; Charles H Goldsmith; Zenglong Zhu; Sonja DePauw; Margaret Denton; Michael Boyle
Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.
Medical care 2002;40(2):113-28.
2002: David Feeny; Marie Townsend; William Furlong; Darrell J Tomkins; Gail Erlick Robinson; George W Torrance; Patrick Mohide; Qinan Wang
Health-related quality-of-life assessment of prenatal diagnosis: chorionic villi sampling and amniocentesis.
Genetic testing 2002;6(1):39-46.
2001: R Gary Sibbald; George W Torrance; Valery Walker; Cheryl Attard; P MacNeil
Cost-effectiveness of Apligraf in the treatment of venous leg ulcers.
Ostomy/wound management 2001;47(8):36-46.
2001: William Furlong; David Feeny; George W Torrance; R D Barr
The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies.
Annals of medicine 2001;33(5):375-84.
2001: George W Torrance; David Feeny; William Furlong
Visual analog scales: do they have a role in the measurement of preferences for health states?
Medical decision making : an international journal of the Society for Medical Decision Making 2001;21(4):329-34.
2000: Kathryn J Bennett; George W Torrance; Michael H Boyle; Richard Guscott
Cost-utility analysis in depression: the McSad utility measure for depression health states.
Psychiatric services (Washington, D.C.) 2000;51(9):1171-6.
2000: Daniel Grima; George W Torrance; G Francis; G Rice; Andrew Rosner; Louise Lafortune
Cost and health related quality of life consequences of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(2):91-8.
2000: Kathryn J Bennett; George W Torrance; Michael H Boyle; Richard Guscott; L A Moran
Development and testing of a utility measure for major, unipolar depression (McSad).
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000;9(1):109-20.
1999: George W Torrance; Valery Walker; R Grossman; J Mukherjee; D Vaughan; J La Forge; N Lampron
Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year.
PharmacoEconomics 1999;16(5 Pt 1):499-520.
1999: J L Glennie; George W Torrance; J F Baladi; C Berka; E Hubbard; D Menon; N Otten; M Rivière
The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.
PharmacoEconomics 1999;15(5):459-68.
1998: Andrew Rosner; Daniel Grima; George W Torrance; C Bradley; J D Adachi; R J Sebaldt; D J Willison
Cost effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis.
PharmacoEconomics 1998;14(5):559-73.
1998: Bernie J O'Brien; R Goeree; Amiram Gafni; George W Torrance; M V Pauly; H Erder; JJ Rusthoven; J Weeks; M Cahill; B LaMont
Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care.
Medical care 1998;36(3):370-84.
1997: Jeremiah Hurley; Stephen Birch; Gregory L Stoddart; George W Torrance
Medical necessity, benefit and resource allocation in health care.
Journal of health services research & policy 1997;2(4):223-30.
1997: Kathryn J Bennett; George W Torrance; L A Moran; F Smith; Charles H Goldsmith
Health state utilities in knee replacement surgery: the development and evaluation of McKnee.
The Journal of rheumatology 1997;24(9):1796-805.
1997: George W Torrance
Preferences for health outcomes and cost-utility analysis.
The American journal of managed care 1997;3 Suppl():S8-20.
1996: D Menon; F Schubert; George W Torrance
Canada's new guidelines for the economic evaluation of pharmaceuticals.
Medical care 1996;34(12 Suppl):DS77-86.
1996: George W Torrance; David Feeny; William Furlong; Ronald D Barr; Y Zhang; Q Wang
Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2.
Medical care 1996;34(7):702-22.
1996: George W Torrance; D Blaker; A Detsky; W Kennedy; F Schubert; D Menon; P Tugwell; R Konchak; E Hubbard; T Firestone
Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics.
PharmacoEconomics 1996;9(6):535-59.
1995: Bernie J O'Brien; S Novosel; George W Torrance; D Streiner
Assessing the economic value of a new antidepressant. A willingness-to-pay approach.
PharmacoEconomics 1995;8(1):34-45.
1995: George W Torrance; William Furlong; David Feeny; M Boyle
Multi-attribute preference functions. Health Utilities Index.
PharmacoEconomics 1995;7(6):503-20.
1995: David Feeny; William Furlong; M Boyle; George W Torrance
Multi-attribute health status classification systems. Health Utilities Index.
PharmacoEconomics 1995;7(6):490-502.
1995: M H Boyle; William Furlong; David Feeny; George W Torrance; J Hatcher
Reliability of the Health Utilities Index--Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1995;4(3):249-57.
1994: Saroj Saigal; David Feeny; William Furlong; Peter Rosenbaum; Elizabeth Burrows; George W Torrance
Comparison of the health-related quality of life of extremely low birth weight children and a reference group of children at age eight years.
The Journal of pediatrics 1994;125(3):418-25.
1994: Saroj Saigal; Peter Rosenbaum; B Stoskopf; L Hoult; William Furlong; David Feeny; Elizabeth Burrows; George W Torrance
Comprehensive assessment of the health status of extremely low birth weight children at eight years of age: comparison with a reference group.
The Journal of pediatrics 1994;125(3):411-7.
1993: Ronald D Barr; William Furlong; S Dawson; Anthony C Whitton; I Strautmanis; M Pai; David Feeny; George W Torrance
An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood.
The American journal of pediatric hematology/oncology 1993;15(3):284-90.
1993: Neil B Oldridge; William Furlong; David Feeny; George W Torrance; G Guyatt; J Crowe; N Jones
Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction.
The American journal of cardiology 1993;72(2):154-61.
1993: David Feeny; A Leiper; Ronald D Barr; William Furlong; George W Torrance; Peter Rosenbaum; S Weitzman
The comprehensive assessment of health status in survivors of childhood cancer: application to high-risk acute lymphoblastic leukaemia.
British journal of cancer 1993;67(5):1047-52.
1992: David Feeny; William Furlong; Ronald D Barr; George W Torrance; Peter Rosenbaum; S Weitzman
A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(6):923-8.
1991: Neil B Oldridge; G Guyatt; N Jones; J Crowe; J Singer; David Feeny; Robert S McKelvie; J Runions; D Streiner; George W Torrance
Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction.
The American journal of cardiology 1991;67(13):1084-9.
1989: David Feeny; George W Torrance
Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples.
Medical care 1989;27(3 Suppl):S190-204.